Abbott Laboratories was ordered to pay $495 million after a jury found it failed to warn that its formula for premature infants increased risk for a bowel disease.
Abbott Laboratories was ordered to pay $495 million after a jury found it failed to warn that its formula for premature infants increased risk for a bowel disease.